Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Michael Vaslamatzis"'
Autor:
Kalliopi Athanassiadi, Ilias Samiotis, Evangelia Chatzimichali, Aikaterini Katsandri, Nikolina Stavrinou, Stylianos Benakis, D Magouliotis, Theodoros Tegos, Michael Vaslamatzis
Publikováno v:
Surgical Case Reports. :1-3
Angiosarcoma is a rare soft tissue highly malignant tumor of vascular origin, accounting for only 1% to 2% of these tumors. We present a rare case of De novo (unrelated to irradiation or pyothorax) angiosarcoma of the thoracic outlet with a 10-year d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::718e33fc7fb5ecf8c00d049635d1c3c1
https://doi.org/10.31487/j.scr.2020.11.14
https://doi.org/10.31487/j.scr.2020.11.14
Autor:
Michael Vaslamatzis, Aikaterini Katsandri, Konstantinos Antonopoulos, Ioannis Alevizakis, Kalliopi Athanassiadi, Pantelis Kourgiantakis, Ioanna Sigala, Dimitrios E Magouliotis, Christina Routsi, S. Zakynthinos, Konstantina Romana, Niki Gianniou, Aikaterini Maragkouti
Publikováno v:
Thoracic surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::828f2a7a950e69c44922db59a2be2165
https://doi.org/10.1183/13993003.congress-2020.1709
https://doi.org/10.1183/13993003.congress-2020.1709
Publikováno v:
Journal of Thoracic Oncology. 14:S972-S973
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55cc81f1a028cd439cd6ca4d6efce991
https://doi.org/10.1016/j.jtho.2019.08.2132
https://doi.org/10.1016/j.jtho.2019.08.2132
Autor:
Nektarios Alevizopoulos, M. Pavlakis, K. Gioti, Michael Vaslamatzis, Theodoros Tegos, V. Sioufi, K. Folinas, V. Edvin, V. Nikolaidou, Charalambos Stathopoulos
Publikováno v:
Journal of Thoracic Oncology. 14:S943-S944
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d580da8ebc755f8aa17391ff4dbe4f03
https://doi.org/10.1016/j.jtho.2019.08.2057
https://doi.org/10.1016/j.jtho.2019.08.2057
Autor:
M. Pavlakis, K. Karagiorgou, Elisavet Patila, K. Gioti, Nektarios Alevizopoulos, Charalambos Zisis, D. Exarchos, Theodoros Tegos, Michael Vaslamatzis
Publikováno v:
Journal of Thoracic Oncology. 14:S1021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ade2adeb6a5be7d2cb39ed7bddab9eca
https://doi.org/10.1016/j.jtho.2019.08.2259
https://doi.org/10.1016/j.jtho.2019.08.2259
Autor:
K. Athanasiadou, K. Gioti, K. Karagiorgou, Theodoros Tegos, M. Pavlakis, H. Kyriazidou, Michael Vaslamatzis, Nektarios Alevizopoulos, Charalambos Zoumblios, E. Balis, V. Nikolaidou
Publikováno v:
Journal of Thoracic Oncology. 14:S663
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7f12e6b01a672135172dc0022c1b0c3
https://doi.org/10.1016/j.jtho.2019.08.1404
https://doi.org/10.1016/j.jtho.2019.08.1404
Autor:
Michael Vaslamatzis, P. Makrantonakis, Athanasios Athanasiadis, Athina Christopoulou, Charalampos Christofyllakis, Christos Emmanouilides, Iliada Bompolaki, Ioannis Sougklakos, Stylianos Kakolyris, Nikolaos Ziras, Efthimios Prinarakis, Nikolaos K. Kentepozidis, Ageliki Kalisperi, Spyros Xynogalos, Ioannis Boukovinas, Alexandros Ardavanis, Charalambos Kouroussis, Nikolaos Androulakis, Dimitrios Mavroudis, Vassilis Georgoulias
Publikováno v:
Journal of Clinical Oncology. 37:3500-3500
3500 Background: The IDEA aimed to investigate whether a 3-month (3M) of oxaliplatin/fluoropyrimidines-based adjuvant chemotherapy (CT) is non-inferior to the 6-month (6M) in 3-year disease free survival (DFS) in stage high risk stage II and in stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b70de71478db5f12f5feaf5cf173f1b
https://doi.org/10.1200/jco.2019.37.15_suppl.3500
https://doi.org/10.1200/jco.2019.37.15_suppl.3500
Autor:
Vassilis Georgoulias, Michail Nikolaou, Athina Christopoulou, Athanasios Kotsakis, Alexandros Ardavanis, Nikolaos K. Kentepozidis, P. Makrantonakis, Vasiliki Michalaki, Aristidis Polyzos, Christos Emmanouilides, Ilias Athanasiadis, Nikolaos Ziras, Michael Vaslamatzis, Nikolaos Vardakis
Publikováno v:
Journal of Clinical Oncology. 37:5562-5562
5562 Background: The standard of care for Epithelial Ovarian cancer (EOC) is the combination of a taxane plus a platinum compound (TC) whereas the addition of bevacizumab (bev) to this regimen (TC-bev) has been shown to improve the PFS. Patients (pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72293035df2f25f20f7fd772d498fe45
https://doi.org/10.1200/jco.2019.37.15_suppl.5562
https://doi.org/10.1200/jco.2019.37.15_suppl.5562
Autor:
Michael Vaslamatzis, Edvin Vasili, Charalambos Zoumblios, Elisavet Patila, Charalambos Zisis, Theodoros Tegos, Nektarios Alevizopoulos, Apostolos Laskarakis, Charalambos Stathopoulos, Theodora Kapou
Publikováno v:
Journal of Thoracic Oncology. 12:S905-S906
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a92cacfc768389614414bf35e36afe8
https://doi.org/10.1016/j.jtho.2016.11.1238
https://doi.org/10.1016/j.jtho.2016.11.1238
Autor:
Nickie Loukas, Vasiliki Ntalapera, Anna Skoula, Nektarios Alevizopoulos, Theodoros Vagdatlis, Michael Vaslamatzis, Ioanna Sigala, Theodoros Tegos, Areti Dimitriadou
Publikováno v:
Journal of Thoracic Oncology. 12:S1022-S1023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7f71935e28f5421784f0044d6013557
https://doi.org/10.1016/j.jtho.2016.11.1422
https://doi.org/10.1016/j.jtho.2016.11.1422